Affinity Meeting:
Engineering/IT/Science & Baker IDI
Thursday 26th June 2014
3:30pm-5:30pm
Level 7 Meeting Room
Baker IDI Heart and Diabetes Institute
75 Commercial Rd Melbourne 3004
AGENDA
The Monash campus and associated hospitals provides a rich environment for research collaborations
in the health science space. This meeting is the first step to bring together engineering academics and
clinicians from medicine together to focus on the development of three clinically focussed research
initiatives where engineering innovation can support clinical need. This is part of the Monash Institute
of Medical Engineering (MIME) initiative.
1. Overview & Introductions
2. Presentations by clinicians (2 minutes each, 1-slide
presentation) on clinical practice problem/issue with a
potential Engineering and/or IT solution
Frieder Seible
Jennings
Medicine
&
3. Presentations by selected Engineers/IT/Science staff (2minutes, 1-slide) on capabilities
Engineering/IT/Science
4. Open discussions re possible synergies
ALL
5. Next Steps
Murray Rudman
6. Closing
Murray Rudman
Garry
Summary of Baker interests
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)
11)
12)
13)
Design and construction of an optical intravascular catheter.
Nanoparticles for imaging and drug delivery.
Microfluidics for the study of blood flow and plasmatic and cellular coagulation
Generation and use of recombinant antibodies for molecular imaging and smart delivery
Targeted nanoscale systems for "intelligent" drug release and safe treatment of thrombosis,
inflammation and cancer
Development of "biobetter" antibodies with added functionality
Bio-enzymatic conjugation methods
Targeted poly-lysine dendrimers with unique point of attachment for drug delivery and imaging
(MRI, PET/SPECT, photoacoustic and fluorescence imaging
Next generation diagnostic assays
Cardiac imaging
Non-invasive cardiac pressure measurement
In assessing contribution of bio-mechanics to plaque stability
Mechanical aspects of pressure in contribution to our studies on pressure induced vascular
inflammation (in context of hypertension).
ATTENDEES
Baker IDI, Alfred Health and Faculty of Medicine, Nursing & Health Sciences
Prof. Christina Mitchell
Dean, Faculty of Medicine, Nursing & Health Sciences (to be
confirmed)
Prof. Garry Jennings
Director, Baker IDI
Sarah Newton
Deputy Dean, External Engagement, FMNHS
Prof. Tony Dart
Director, Cardiovascular Medicine, Alfred
Prof. Karlheinz Peter
Associate Director, Atherothrombosis & Vascular, Baker IDI
Dr Christoph Hagemeyer
Senior Research Fellow, Vascular Biotechnology, Baker IDI
Mr Guy Kripner
Executive General Manager, Commercialisation and Contracts,
Baker IDI
Prof Karin Jandeleit-Dahm
Lab Head, Diabetic Complications - Diabetes & Kidney Disease,
Baker IDI
Prof Neville Owen
Lab Head, Behavioural Epidemiology, Baker IDI
Dr Melissa Byrne
Pre-Clinical Research Manager, Heart Failure Research Group,
Baker IDI
Dr Ross Lazarus
Lab Head, Medical Bioinformatics, Baker IDI
Prof Jaye Chin-Dusting
Executive Director, Science Strategy, Baker IDI
Assoc Prof Andrew Taylor
Director of Cardiac MRI, Head of Non-Invasive Imaging, Cardiology
General, Alfred
Dr Andrew Carey
Post Doctoral Research Officer, Metabolic & Vascular Physiology,
Baker IDI
Assoc Prof Silvana Marasco
Cardiothoracic Unit, Alfred
Faculties of Engineering and Information Technology
Prof. Freider Seible
Dean, Faculty of Engineering
Dean, Faculty of Information Technology
Prof. Maria Garcia de la Banda
Deputy Dean, Faculty of Information Technology
Prof. Murray Rudman
Dept. Mechanical and Aerospace Engineering
Assoc. Prof. Adrian Neild
Dept. Mechanical and Aerospace Engineering
Assoc. Prof. Andreas Fouras
Dept. Mechanical and Aerospace Engineering
Assoc. Prof. John Forsythe
Dept. Materials Engineering
Dr Mehmet Yuce
Dept. of Electrical and Computer Systems Engineering
Assoc. Prof. Wenlong Cheng
Dept. of Chemical Engineering
Dr Josie Carbery
Dept. Mechanical and Aerospace Engineering
Faculty of Science
Assoc Prof Bayden Wood
Dr Marcus Kitchen
Dr Robert Bryson-Richardson
School of Chemistry
School of Physics
School of Biological Sciences
MIME
Dr Heather St John
Chief Operations Officer, MIME